Shenouda, S K; Carvalho, F; Varner, K J (2010) The cardiovascular and cardiac actions of ecstasy and its metabolites. Curr Pharm Biotechnol 11:470-5
|
Hicks, Alissa R; Ogden, Brian A; Varner, Kurt J (2003) Cardiovascular responses elicited during binge administration of cocaine. Physiol Behav 80:115-22
|
Varner, Kurt J; Ogden, Brian A; Delcarpio, Joseph et al. (2002) Cardiovascular responses elicited by the ""binge"" administration of methamphetamine. J Pharmacol Exp Ther 301:152-9
|
Varner, K J; Hein, N D; Ogden, B A et al. (2001) Chloroephedrine: contaminant of methamphetamine synthesis with cardiovascular activity. Drug Alcohol Depend 64:299-307
|
O'Cain, P A; Hletko, S B; Ogden, B A et al. (2000) Cardiovascular and sympathetic responses and reflex changes elicited by MDMA. Physiol Behav 70:141-8
|
Cabral, A D; Kapusta, D R; Kenigs, V A et al. (1998) Central alpha2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia. Am J Physiol 275:R1867-74
|
Petersen, J S; Liu, W; Kapusta, D R et al. (1997) Metformin inhibits ganglionic neurotransmission in renal nerves. Hypertension 29:1173-7
|
Cabral, A M; Varner, K J; Kapusta, D R (1997) Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats. J Pharmacol Exp Ther 282:609-16
|
Liu, W; Varner, K J (1996) Characterization of the sympathetic nerve responses to amphetamine: role of central alpha 2-adrenergic receptors. J Cardiovasc Pharmacol 28:712-22
|
Abrahams, T P; Faust, M L; Varner, K J (1996) The depletion of monoamines blocks the sympathoinhibitory response to cocaine. J Auton Nerv Syst 58:170-6
|
Showing the most recent 10 out of 12 publications